Ipsen

Ipsen
Type	Public (Euronext: IPN)
Industry	Pharmaceutical
Founded	1929
Headquarters	Paris, France
Products	Targeted therapeutic areas : oncology, endocrinology and neuromuscular disorders; Primary care treatments (mainly in France): gastroenterology, cognitive disorders and cardiovascular;
Employees	nearly 4,400
Website	www.ipsen.com

From Wikipedia, the free encyclopedia

Jump to: navigation, search

Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. In 2005, Ipsen spent € 169 million—20.9% of consolidated sales—on research and development, according to the IFRS.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.